242 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 5 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Nuclear bodies
Expressed in all
ACVR1Activin A receptor type 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli
Cytosol
Urothelial cancer: 5.17e-4
Expressed in all
ACVR2AActivin A receptor type 2ACancer-related genes
Enzymes
Predicted membrane proteins
CytosolRenal cancer: 1.62e-4
Mixed
AKT1AKT serine/threonine kinase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleus
Microtubules
Renal cancer: 2.12e-4
Ovarian cancer: 4.83e-4
Expressed in all
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
AMER1APC membrane recruitment protein 1Cancer-related genes
Disease related genes
Predicted intracellular proteins
Nuclear bodies
Vesicles
Plasma membrane
Mixed
APCAPC, WNT signaling pathway regulatorCancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
ARAndrogen receptorCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
MitochondriaRenal cancer: 1.03e-8
Liver cancer: 8.77e-4
Mixed
ARID1AAT-rich interaction domain 1ACancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmLiver cancer: 4.18e-4
Expressed in all
ARID1BAT-rich interaction domain 1BCancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmBreast cancer: 1.04e-4
Ovarian cancer: 4.16e-4
Expressed in all
ASXL1Additional sex combs like 1, transcriptional regulatorCancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleus
Nucleoli
Endometrial cancer: 2.86e-4
Head and neck cancer: 9.16e-4
Expressed in all
ATMATM serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmExpressed in all
ATP1A1ATPase Na+/K+ transporting subunit alpha 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 8.98e-8
Liver cancer: 1.42e-4
Urothelial cancer: 4.01e-4
Expressed in all
ATRXATRX, chromatin remodelerCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Transcription factors
Nuclear bodiesExpressed in all
AXIN1Axin 1Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleoli
Vesicles
Liver cancer: 3.38e-5
Expressed in all
AXIN2Axin 2Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleus
Plasma membrane
Cytosol
Pancreatic cancer: 6.58e-4
Mixed
BAP1BRCA1 associated protein 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 3.29e-7
Expressed in all
BCL6B-cell CLL/lymphoma 6Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Golgi apparatus
Renal cancer: 1.27e-9
Expressed in all
BCL9LB-cell CLL/lymphoma 9-likeCancer-related genes
Predicted intracellular proteins
NucleoplasmExpressed in all
BCORL1BCL6 corepressor-like 1Cancer-related genes
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Endometrial cancer: 2.20e-5
Renal cancer: 5.00e-4
Expressed in all
BIRC3Baculoviral IAP repeat containing 3Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 6.66e-6
Pancreatic cancer: 3.03e-4
Breast cancer: 3.60e-4
Colorectal cancer: 9.35e-4
Tissue enhanced
BLMBloom syndrome RecQ like helicaseCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nucleus
Cytosol
Mixed
BMPR1ABone morphogenetic protein receptor type 1ACancer-related genes
CD markers
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
CytosolLiver cancer: 8.93e-4
Glioma: 9.38e-4
Mixed
BRAFB-Raf proto-oncogene, serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Vesicles
Cytosol
Expressed in all
BRCA1BRCA1, DNA repair associatedCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Mixed
BRCA2BRCA2, DNA repair associatedCancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Tissue enhanced
BRIP1BRCA1 interacting protein C-terminal helicase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleus
Nuclear membrane
Colorectal cancer: 3.45e-5
Head and neck cancer: 3.62e-4
Tissue enhanced
BTKBruton tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
VesiclesTissue enhanced
BUB1BBUB1 mitotic checkpoint serine/threonine kinase BCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
CytosolLiver cancer: 7.43e-6
Pancreatic cancer: 1.79e-4
Lung cancer: 3.56e-4
Tissue enhanced
CACNA1DCalcium voltage-gated channel subunit alpha1 DCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneRenal cancer: 8.34e-8
Mixed
CALRCalreticulinCancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.11e-16
Ovarian cancer: 1.10e-4
Expressed in all
CARD11Caspase recruitment domain family member 11Cancer-related genes
Disease related genes
Predicted intracellular proteins
Renal cancer: 6.68e-8
Urothelial cancer: 1.10e-4
Tissue enhanced
CBLCbl proto-oncogeneCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
CytosolMixed
CBLBCbl proto-oncogene BCancer-related genes
Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
CD79BCD79b moleculeCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cytosol
Head and neck cancer: 2.35e-4
Group enriched
CDC73Cell division cycle 73Cancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleus
Cytosol
Expressed in all
CDH1Cadherin 1Cancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Plasma membrane
Cell Junctions
Renal cancer: 2.06e-4
Tissue enhanced
CDK12Cyclin dependent kinase 12Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
NucleusExpressed in all
CDK4Cyclin dependent kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Nuclear membrane
Nucleoli
Cytosol
Liver cancer: 2.09e-7
Renal cancer: 3.15e-5
Expressed in all
CDKN2ACyclin dependent kinase inhibitor 2ACancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
NucleoliEndometrial cancer: 1.82e-7
Renal cancer: 5.76e-7
Liver cancer: 2.17e-4
Head and neck cancer: 5.19e-4
Mixed
CEBPACCAAT/enhancer binding protein alphaCancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Vesicles
Expressed in all
CHD4Chromodomain helicase DNA binding protein 4Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleusLiver cancer: 6.03e-6
Expressed in all
CICCapicua transcriptional repressorCancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Vesicles
Expressed in all
CNOT3CCR4-NOT transcription complex subunit 3Cancer-related genes
Predicted intracellular proteins
CytosolLiver cancer: 2.22e-4
Renal cancer: 2.77e-4
Expressed in all
COL2A1Collagen type II alpha 1 chainCancer-related genes
Disease related genes
Predicted secreted proteins
NucleoplasmGroup enriched
CREBBPCREB binding proteinCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Renal cancer: 6.24e-5
Expressed in all
CRLF2Cytokine receptor-like factor 2Cancer-related genes
Predicted membrane proteins
Tissue enhanced
CSF3RColony stimulating factor 3 receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Testis cancer: 3.79e-4
Renal cancer: 5.72e-4
Tissue enhanced
CTCFCCCTC-binding factorCancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmRenal cancer: 4.06e-4
Liver cancer: 4.21e-4
Expressed in all
CTNNB1Catenin beta 1Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membraneColorectal cancer: 7.54e-4
Expressed in all
Page of 5 | next »